Faro AI Raises $37.3M for Clinical Data
Faro AI raised $37.3M for clinical data infrastructure, with strategic healthcare investors joining the round.
Clinical development is becoming another important market for AI-ready data infrastructure.
What happened
Faro AI raised a $37.3M Series B. Merck Global Health Innovation Fund and S32 led, with Ankona Capital and insiders including General Catalyst, Northpond Ventures, Polaris Partners, PTX Capital and Zetta participating.
Why it matters
Drug development depends on high-quality clinical data, but trials remain complex, fragmented and expensive. Better data infrastructure can help teams design, monitor and analyse trials more effectively.
The investor mix also suggests strategic interest from the healthcare and life-sciences ecosystem.
The bigger picture
Healthcare AI is not only about diagnosis or chatbots. Some of the most durable value may come from infrastructure that improves how clinical work is organised and measured.